Indie horror comedy “Glue Trap” has been acquired by Gravitas Ventures following a film festival run that began with its premiere last year at Dances With Films. The film, written and directed ...
Do you want to hear the best-sounding portable music player in creation? Something that plays your favorite songs better than you’ve ever heard them? Do you have an extra $3,000, another couple ...
IMPORTANT UPDATE: The tube strikes planned for November 7 and 12 will no longer take place after ASLEF called off industrial action following last ditch talks and an ‘improved offer’ from TfL ...
The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using the company’s QuEEN platform, that makes ...
The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...
Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with its Phase I ...